Am J Transplant, Volume 18, Suppl 3 Archives - Page 149 of 211 - ATC Abstracts

2018 American Transplant Congress
Biochemistry Profiles Following Pig-to-Nonhuman Primate Liver Xenotransplantation
N. Louras, M. Patel, J. Shah, D. Sachs, P. Vagefi.
Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
Objectives:Clinical progress in liver transplantation has increased the demand for organs, however, supply remains stagnant. Porcine liver xenotransplantation (LXT) would help address this imbalance. Here…
2018 American Transplant Congress
HLA Typing, Panel Reactive Antibody and Donor Specific Antigen Tests Are Not Necessary for Successful Parathyroid Allotransplantation
E. Kanimdan,¹ B. Goncu,² Y. Gelmez,³ O. Idiz,⁴ C. Toka,⁵ B. Ozdemir,² H. Basoglu,⁶ N. Ozten Kandas,⁷ E. Yucesan,⁸ Y. Ersoy,⁵ R. Kazancioglu,⁹ E. Aysen.⁵
¹Bezmialem Vakif University, Faculty of Medicine, Department of Medical Biology, Istanbul, Turkey; ²Bezmialem Vakif University, Experimental Research Center, Istanbul, Turkey; ³Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Immunology, Istanbul, Turkey; ⁴Istanbul Training and Research Hospital, Department of General Surgery, Istanbul, Turkey; ⁵Bezmialem Vakif University, Faculty of Medicine, Department of General Surgery, Istanbul, Turkey; ⁶Bezmialem Vakif University, Faculty of Medicine, Department of Biophysics, Istanbul, Turkey; ⁷Bezmialem Vakif University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Istanbul, Turkey; ⁸Bezmialem Vakif University, Institute of Life Sciences and Biotechnology, Istanbul, Turkey; ⁹Bezmialem Vakif University, Faculty of Medicine, Department of Internal Medicine, Istanbul, Turkey.
Permanent hypoparathyroidism(PH) is incurable condition and requires life long drug therapy.Unique therapeutic option is parathyroid allotransplantation(PA).Some studies use routinely but emprically HLA typing,PRA(panel reactive antibody)…
2018 American Transplant Congress
Prediction of Renal Allograft Chronic Rejection Using a Model Based on Contrast EnhancedUltrasonography
C. Yang,¹ S. Wu,³ T. Zhu,¹ W. He.²
¹Urology, Zhongshan Hospital, Fudan University, Shanghai, China; ²Utrasound, Zhongshan Hospital, Fudan University, Shanghai, China; ³Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Contrast-enhanced ultrasonography (CEUS) represents microperfusion status of transplanted kidneys. Herein, we evaluate the application of CEUS in the assessment of renal allograft rejection by establishing…
2018 American Transplant Congress
Impact of Pulsatile Perfusion Machine on Postoperative Outcomes in Standard Criteria Donor Kidney Transplants
S. Costa,^1,2 T. Sandes-Freitas,^1,2 P. Fernandes,² R. Esmeraldo.¹
¹Hospital Geral de Fortaleza, Fortaleza, Brazil; ²Universidade Federal do Ceara, Fortaleza, Brazil.
Introduction: Delayed graft function (DGF) negatively impacts kidney transplant (KT) outcomes. Our aim was to assess the impact of pulsatile machine perfusion (MP) on KT…
2018 American Transplant Congress
Simplified Once-Daily Immunosuppressive Regimen for Stable Kidney Recipients
S. Lee,¹ K. Huh,² J. Jeon,³ S-.J. Kim,⁴ Y. Kim,² C-.K. Oh.¹
¹Surgery, Ajou University School of Medicine, Suwon, Korea; ²Surgery, Severance Hospital, Yonsei University Health System, Seoul, Korea; ³Nephrology, Soon Chun Hyang University Hospital, Seoul, Korea; ⁴Surgery, Samsung Medical Center, Seoul, Korea.
Background. Many immunosuppressive drugs are prescribed as twice-daily dosing. Simplified once-daily dosing of the entire drug regimen can improve treatment satisfaction for patients. We examined…
2018 American Transplant Congress
Does One Size Fit All? Implementing a Protocolized Ambulatory Tacrolimus Dosing Strategy in a Predominantly African American Renal Transplant Population
L. Gylten, C. Mardis, D. Taber, H. Meadows, C. Perez, Z. Elmaasarani, J. Fleming, N. Patel, P. Baliga, V. Rao, V. Rohan, N. Pilch.
Medical University of South Carolina, Charleston, SC.
Introduction: African American (AA) KTx recipients have significant tacrolimus (FK) inter patient variability making protocolized dosage adjustment challenging. We sought to evaluate the efficacy &…
2018 American Transplant Congress
Evaluation of Tacrolimus Extended-Release in African American Renal Transplant Recipients
T. Sparkes, B. Ravichandran, C. Williams, B. Thomas, B. Masters.
University of Maryland, Baltimore.
Purpose: Limited data exists to guide appropriate dosing strategies for novel tacrolimus formulations, such as tacrolimus XL (Astagraf XL). This is especially true in the…
2018 American Transplant Congress
The Infusion with a Difference: Patient Experiences with Belatacept
H. Murad, D. Malhotra, E. Cohen, W. Asch.
Yale University, New Haven, CT.
Introduction: The results of the BENEFIT trial led to the FDA approval of the novel anti-rejection agent belatacept (bela) in 2011. In addition to its…
2018 American Transplant Congress
Efficacy of Current Educational Interventions in Improving Living Donor Kidney Transplantation Rates
S. Sandal, N. Dendukuri, S. Wang, E. Guadagno, T. Ekmekjian, A. Alam.
McGill Unversity Health Center, Montreal, Canada.
IntroductionLack of knowledge and discomfort approaching a donor are two of the most common recognized, recipient-level barriers to living donor kidney transplantation (LDKT). To address…
2018 American Transplant Congress
How Old is Too Old? Expanding Living Kidney Organ Transplantation from Donors above 60 Years of Age with Associated Comorbidity.
A. Ghazanfar, L. Salih.
Transplant Surgery, St Georges University Hospital NHS Foundation Trust, London, United Kingdom.
Background: Worldwide the population is ageing. In UK there are more people above 60 than under 16 years of age. Hence there are more elderly…